Startups
Specific cancers: New molecules to increase the survival rate of patients :
Sphingosine-1-phosphate (S.1.p) and cationic amphipathic peptide (CAP6).
Sphingosine-1-phosphate (S.1.p) and cationic amphipathic peptide (CAP6).
Overview
Employees
11-50
Total raised
$996.6K
Founded date
2017
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 21, 2022 | Seasoned Board Members for Swiss Startups | |
| Dec 18, 2020 | AC BioScience moves towards clinical trials | From its headquarters at the life sciences campus Biopôle, AC BioScience is pioneering the development of novel therapies in immune-oncology and tumour vascular normalization. Since 2017, the company has been identifying and developing mole... |
| Dec 18, 2020 | AC BioScience moves towards clinical trials | |
| Jun 12, 2020 | New StartLab Program set on growth | Launched in 2018, StartLab the Vaud based Swiss Life Sciences Incubator has attracted 11 promising ventures such as Amazentis, AC Biosciences or Basel based Cellestia Biotech to name a few. For Nasri Nahas, Biopôle’s CEO, StartLab’s unique ... |
| Jun 12, 2020 | New StartLab Program set on growth | |
| May 25, 2020 | Additional capital for AC BioScience | |
| May 25, 2020 | Additional capital for AC BioScience | AC BioScience is a biotech company pioneering the development of novel therapies in immuno-oncology and tumour vascular normalisation. Based on molecular profiling, the startup develops personalized molecular therapies designed to optimize ... |
| Apr 1, 2019 | Swiss Biotech Day to shed light on 13 emerging startups | |
| Mar 13, 2019 | AC Bioscience secures CHF 1 million in a seed round |
Reviews 0
FAQ about AC BioScience
When was AC BioScience founded?
AC BioScience was founded in 2017.
How much funding has AC BioScience raised?
AC BioScience has raised $996.6K in total across 1 funding round.
What has the press written about AC BioScience?
Parsers VC has collected 10 articles mentioning AC BioScience, among them “Seasoned Board Members for Swiss Startups” (Mar 21, 2022) and “AC BioScience moves towards clinical trials” (Dec 18, 2020).
Is AC BioScience still active?
Yes, AC BioScience is active; its latest activity on Parsers VC dates from Aug 26, 2022.